Calculation of trough: Peak ratio of antihypertensive treatment from ambulatory blood pressure: Methodological aspects

Journal of Hypertension

Volumn 13, Issue 10, 1995, Pages 1105-1112

  Omboni, Stefano ^a   Parati, Gianfranco ^b   Zanchettit, Alberto ^c   Mancia, Giuseppe ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Ambulatory blood pressure; Antihypertensive treatment; Blood pressure variability; Placebo; Trough: peak ratio

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BORDERLINE HYPERTENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0028846991     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199510000-00005     Document Type: Article

References (39)

1. Rose M, MacMahon FC: Some problems with antihypertensive drug studies in the context of the new guidelines. Am J Hypertens 1990, 3:151-155.
2. Lipicky RJ: Trough:peak ratio: the rationale behind the United States Food and Drug Administration recommendations. J Hypertens 1994, 12 (suppl 8): S17-S19.
3. Guntzel P, Kobrin I, Pasquier C, Zimlichman R, Viskoper JR: The effect of ciiazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patients. J Cardiovasc Pharmacol 1991, 17:8-12.
4. Felicetta JV, Serfer HM, Cutler NR, Comstock TJ, Huber CL, Weir MR, et al.: A dose-response trial of once-daily diltiazem. Am Heart J 1992, 123:1022-1026.
5. Lacourcière Y, Poirier L, Provencher P, Myron P: Antihypertensive effects of ciiazapril, 2.5 and 5 mg, once daily versus placebo on ambulatory blood pressure following single- and repeated-dose administration. J Cardiovasc Pharmacol 1991, 18:219-223.
6. Zannad F: Trandolapril: how does it differ from other angiotensin converting enzyme inhibitors? Drugs 1993, 46 (suppl 2): 172-182.
7. Zanchetti A on behalf of the Italian Nifedipine CITS Study Croup: Antihypertensive effects of nifedipine GITS on clinic and ambulatory blood pressures in essential hypertensives. High Blood Press 1994, 3:45-56.
8. Mancia G, Zanchetti A: Blood pressure variability. In Handbook of Hypertension. Edited by Zanchetti A, Tarazi RC. Amsterdam: Elsevier, 1986, 7:125-152.
9. Gould BA, Mann S, Davies AB, Altman DC, Raftery EB: Does placebo lower blood pressure? Lancet 1981, ii:1377-1381.
10. Dupont AG, van der Niepen P, Six RO: Placebo does not lower ambulatory blood pressure. Br J Clin Pharmacol 1987, 24:196-109.
11. Mutti E, Trazzi S, Omboni S, Parati G, Mancia G: Effect of placebo on 24 h non-invasive ambulatory blood pressure. J Hypertens 1991, 9:361-364.
12. Staessen JA, Thijs L, Clement D, Davidson C, Fagard R, Lehto-nen A, et al. on behalf of the Syst-Eur Investigators: Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension, J Hypertens 1994, 12:1035-1039.
13. Mancia G, Omboni S, Parati G, Ravogli A, Villani A, Zanchetti A: Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995, 8:311-315.
14. Di Rienzo M, Grassi G, Pedotti A, Mancia G: Continuous versus intermittent blood pressure measurement in estimating 24- hour average blood pressure. Hypertension 1983, 5:264-269.
15. Zanchetti A on behalf of the Italian Nifedipine GITS Study Group: Trough: peak ratio of the blood pressure response to dihydropyridine calcium antagonists. J Hypertens 1994, 12 (suppl 8): S97-S106.
16. Staessen JA, Thijs L, Mancia G, Parati G, O’Brien ET on be- 31. half of the Syst-Eur Investigators: Clinical trials with ambulatory blood pressure monitoring; fewer patients needed? Lancet. 1994, 344:1552-1556.
17. Menard J, Chatellier G, Day M, Vaur L: Self-measurement of blood pressure at home to evaluate drug effects by the trough:peak ratio. J Hypertens 1994, 12 (suppl 8): S21-S25.
18. Elliot HL: Trough-.peak ratio and 24h blood pressure control. J Hypertens 1994, 12 (suppl 5): S29-S33.
19. Meredith PA, Reid JL: Differences between calcium antagonists: duration of action and trough to peak ratio, J Hypertens 1993, 11 (suppl 1): S21-S26.
20. Mancia G, Frattola A, Groppelli A, Omboni S, Parati G, Ulian L, et al.: Blood pressure reduction and end-organ damage in hypertension. J Hypertens 1994, 12 (suppl 8): S35-S42.
21. The Italian Trandolapril Study Group: Evaluation of the anti hypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. Am J Cardiol 1992, 70:60D-66D.
22. The Italian Verapamil Study Group: 24-Hour antihypertensive effect of verapamil sustained release 240 mg versus nitrendipine and enalapril in essential hypertension. High Blood Press 2:241-248.
23. Omboni S, Ravogli A, Fogari R, Riva D, Mancia G: Effects of once-a-day fosinopril on 24-hour ambulatory blood pressure 39. in mild and moderate essential hypertension. High Blood Press 3:103-107.
24. Groppelli A, Omboni S, Parati G, Mancia G: Evaluation of non- invasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension 1992, 20:227-232.
25. Casadei R, Parati G, Pomidossi G, Groppelli A, Trazzi S, Di Rienzo M, et al.: 24-Hour blood pressure monitoring; evaluation of SpaceLabs 5300 monitor by comparison with intra-arterial blood pressure recording in ambulant subjects. J Hypertens 1988, 6:797-803.
26. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, i:307-310.
27. Conway J, Johnston J, Coats A, Somers V, Sleight P: The use of ambulatory blood pressure monitoring to improve the accuracy and reduce numbers of subjects in clinical trials of antihypertensive treatment. J Hypertens 1988, 6:111-116.
28. Trazzi S, Mutti E, Frattola A, Imholz B, Parati G, Mancia G: Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens 1991, 9:115-119.
29. Mancia G, Omboni S, Parati G, Trazzi S, Mutti E: Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring: implications for studies on antihypertensive drugs. J Hypertens 1992, 10:1531-1535.
30. Mancia G, Ulian L, Parati G, Trazzi S: Increase in blood pressure reproducibility by repeated semi-automatic blood pressure measurements in the clinic environment. J Hypertens 1994, 12:469-473.
31. Tukey JW: Exploratory Data Analysis. New York: Addison Wesley; 1977:39-43.
32. Norusis MJ: SPSS/PC+, update for version 3.0 and version 3.1. Chicago: SPSS Inc.; 1989.
33. Elliott HL, Meredith PA: Methodological considerations in calculation of the trough:peak ratio. J Hypertens 1994, 12 (suppl 8): S3-S7.
34. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G: Relationship of 24 h blood pressure mean and variability to severity of target organ damage. J Hypertens 1987, 5:93-98.
35. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Ana- clerio M, et al.: Clinical relevance of night-time blood pressure and daytime blood pressure variability. Arch Intern Med 1992, 152:1855-1860.
36. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G: Prognostic value of 24 h blood pressure variability. J Hypertens 1993, 11:1133-1137.
37. Mancia G, Omboni S, Ravogli A, Parati G, Zanchetti A: Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Pressure 1995, 4:148-156.
38. Parati G, Castiglioni P, Di Renzo M, Omboni S, Pedotti A, Mancia G: Sequential spectral analysis of 24-hour blood pressure and pulse interval in humans. Hypertension 1990, 16:414-421.
39. Parati G, Di Renzo M, Omboni S, Castiglioni P, Frattola A, Mancia G: Spectral analysis of 24 h blood pressure recordings. Am J Hypertens 1993, 6:188S-193S.